Franklin Resources
CAPR icon

Franklin Resources’s Capricor Therapeutics CAPR Stock Holding History

Franklin Resources’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.05M Buy
43,568
+19,495
+81% +$591K ﹤0.01% 2257
2026
Q1 		$732K Buy
+24,073
New +$641K ﹤0.01% 2314
2025
Q2 		– Sell
-23,332
Closed -$221K – 3041
2025
Q1 		$221K Buy
+23,332
New +$324K ﹤0.01% 2630

Other funds holding CAPR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources's CAPR Position: Q2 2026 in Review

Franklin Resources increased its Capricor Therapeutics (CAPR) stake by 81% in Q2 2026, buying an estimated $591K and bringing the position to 43,568 shares worth $1.05M. The position accounts for ﹤0.01% of the portfolio, ranked #2257.

Franklin Resources first reported a position in CAPR in Q1 2025 and has held it in 3 quarters since. 170 funds tracked by Wall St. Rank hold CAPR as of Q2 2026.

  • Franklin Resources held 43,568 shares of Capricor Therapeutics worth $1.05M as of Q2 2026.
  • Franklin Resources bought 19,495 Capricor Therapeutics shares in Q2 2026, an estimated $591K.
  • Capricor Therapeutics made up ﹤0.01% of Franklin Resources's portfolio in Q2 2026, its #2257 holding.
  • Franklin Resources first reported a position in Capricor Therapeutics in Q1 2025 and has held it in 3 quarters since.
  • 170 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.